Make a Donation

In May 2020 Imperial Prostate concluded the world-leading IP1-PROSTAGRAM study, which demonstrated that a non-invasive MRI is capable of identifying up to twice as many high risk prostate cancers compared to traditional blood tests (PSA). This finding is the first step towards more reliable prostate cancer screening leading to earlier detection and in turn better survivorship.

The PROSTAGRAM is a simple, non-invasive MRI scan which lasts around 15 minutes. It is a simplified version of the full 30-40 minute MRI scan which has been recently recommended by the National Institute for Health and Care Excellence (NICE) as the first-line test for men referred to hospital with a suspicion of prostate cancer. The scan uses magnetism to produce a detailed picture of the prostate. It has no radiation risk making it safe as well as non-invasive.

The PROSTAGRAM was successfully piloted in IP1-PROSTAGRAM, a study of over 400 men across the UK in 2019. But for the PROSTAGRAM to be available through the NHS, we need to complete a national study to see how it can have impact across the UK.

For this study to take place we need to raise £2.5 million. The campaign has already reached over £500,000. In order to realise the ambitions of the campaign we are looking to philanthropists and individuals to support us with gifts at any level.